Title:
ORAL COMPOSITION FOR PREVENTING AND/OR IMPROVING COLD SYMPTOMS
Document Type and Number:
WIPO Patent Application WO/2024/080117
Kind Code:
A1
Abstract:
Provided is an oral composition for preventing and/or improving cold symptoms. This oral composition for preventing and/or improving cold symptoms contains euglena algae. It is preferable for the cold symptoms in this case to be one or more symptoms selected from the group consisting of general malaise, chills, feverishness, fatigue, sneezing, nasal discharge, nasal congestion, sore throat, coughing, joint pain, myalgia and headache. It is preferable for the oral consumption to be a food product, a beverage or a medicine.
Inventors:
NAKASHIMA AYAKA (JP)
SUZUKI KENGO (JP)
SUZUKI KENGO (JP)
Application Number:
PCT/JP2023/034691
Publication Date:
April 18, 2024
Filing Date:
September 25, 2023
Export Citation:
Assignee:
EUGLENA CO LTD (JP)
International Classes:
A23L33/10; A61K35/748; A61P11/02; A61P11/04; A61P11/14; A61P19/02; A61P21/00; A61P29/00
Domestic Patent References:
| WO2015156339A1 | 2015-10-15 | |||
| WO2019108319A1 | 2019-06-06 |
Other References:
ANONYMOUS: "The Virtues of Euglena", CADC-ALBUFEIRA, 7 October 2022 (2022-10-07), XP093159539, Retrieved from the Internet
ANONYMOUS: "The Definitive Midorimushi Dictionary", MIDORIMUSHI, 18 August 2022 (2022-08-18), XP093159542, Retrieved from the Internet
ユーグレナ ヘルスケア・ラボ. [online], 06 July 2022 [retrieved on 14 November 2023], Internet:, non-official translation (Euglena Healthcare Lab.) pp. 1-9
EUGLENA: "Continuous intake of microalgae Euglena maintain and adjust immunity Human clinical trials have confirmed that it suppresses the occurrence of cold symptoms (cold-like symptoms) and the severity of various symptoms. ", EUGLENA - PRESS RELEASE, 1 November 2022 (2022-11-01), XP093159545, Retrieved from the Internet
KAWANO TAKANORI; MIURA ATSUSHI; NAITO JUNKO; NISHIDA NORIHISA; ISHIBASHI KEN-ICHI; ADACHI YOSHIYUKI; OHNO NAOHITO; NAITO YUJI: "High-parameter immune profiling and subjective health assessment of the immunomodulatory effects of paramylon-rich Euglena gracilis EOD-1: A randomized, double-blind, placebo-controlled, parallel-group study", JOURNAL OF FUNCTIONAL FOODS, ELSEVIER BV, NL, vol. 109, 23 September 2023 (2023-09-23), NL , XP087415353, ISSN: 1756-4646, DOI: 10.1016/j.jff.2023.105804
ANONYMOUS: "The Definitive Midorimushi Dictionary", MIDORIMUSHI, 18 August 2022 (2022-08-18), XP093159542, Retrieved from the Internet
ユーグレナ ヘルスケア・ラボ. [online], 06 July 2022 [retrieved on 14 November 2023], Internet:
EUGLENA: "Continuous intake of microalgae Euglena maintain and adjust immunity Human clinical trials have confirmed that it suppresses the occurrence of cold symptoms (cold-like symptoms) and the severity of various symptoms. ", EUGLENA - PRESS RELEASE, 1 November 2022 (2022-11-01), XP093159545, Retrieved from the Internet
KAWANO TAKANORI; MIURA ATSUSHI; NAITO JUNKO; NISHIDA NORIHISA; ISHIBASHI KEN-ICHI; ADACHI YOSHIYUKI; OHNO NAOHITO; NAITO YUJI: "High-parameter immune profiling and subjective health assessment of the immunomodulatory effects of paramylon-rich Euglena gracilis EOD-1: A randomized, double-blind, placebo-controlled, parallel-group study", JOURNAL OF FUNCTIONAL FOODS, ELSEVIER BV, NL, vol. 109, 23 September 2023 (2023-09-23), NL , XP087415353, ISSN: 1756-4646, DOI: 10.1016/j.jff.2023.105804
Attorney, Agent or Firm:
AKIYAMA, Atsushi et al. (JP)
Download PDF:
Previous Patent: SENSOR MODULE
Next Patent: LIQUID DROP EJECTION METHOD AND LIQUID DROP EJECTION DEVICE
Next Patent: LIQUID DROP EJECTION METHOD AND LIQUID DROP EJECTION DEVICE